MRC2 and neoplasm: Compared to the younger patients (≤65 years old), MRC2 expression decreased in the tumor of elderly patients (>65 years old) in the group of BRCA, KIRP, LAML, SKCM, and UCEC, while the expression pattern was reversed in the THYM group (Figure 1C).